In line with Singapore's focus on expanding and strengthening its capabilities in translational and clinical research, the development of a national level, clinical research organisation fills an important gap in the development of human capital and infrastructure as part of the second phase of Singapore's Biomedical Sciences Initiative.

Through National Research Foundation (NRF) funding, the Singapore Clinical Research Institute (SCRI) has been established as a one-stop entity that provides the necessary expertise, support, scientific leadership and scientific collaborations for the conduct of both Investigator initiated and commercially sponsored clinical research studies in Singapore.

The SCRI evolved from the Clinical Trials and Epidemiology Research Unit (CTERU), which was a National Medical Research Council (NMRC) funded unit to help support clinical research in Singapore.

For a brief history of CTERU, please click here.